118.30
-0.45 (-0.38%)
| Previous Close | 118.75 |
| Open | 116.71 |
| Volume | 370,509 |
| Avg. Volume (3M) | 601,003 |
| Market Cap | 4,127,723,776 |
| Price / Earnings (TTM) | 55.02 |
| Price / Earnings (Forward) | 21.64 |
| Price / Sales | 2.45 |
| Price / Book | 2.62 |
| 52 Weeks Range | |
| Earnings Date | 23 Jul 2025 - 28 Jul 2025 |
| Profit Margin | 4.40% |
| Operating Margin (TTM) | 12.67% |
| Diluted EPS (TTM) | 2.15 |
| Quarterly Revenue Growth (YOY) | 7.30% |
| Quarterly Earnings Growth (YOY) | 24.10% |
| Total Debt/Equity (MRQ) | 84.31% |
| Current Ratio (MRQ) | 3.40 |
| Operating Cash Flow (TTM) | 213.24 M |
| Levered Free Cash Flow (TTM) | 110.99 M |
| Return on Assets (TTM) | 4.51% |
| Return on Equity (TTM) | 4.98% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Integer Holdings Corporation | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 1.63 |
|
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 0.89% |
| % Held by Institutions | 116.40% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 150.00 (Truist Securities, 26.80%) | Buy |
| 150.00 (Raymond James, 26.80%) | Buy | |
| Median | 145.00 (22.57%) | |
| Low | 140.00 (Citigroup, 18.34%) | Buy |
| 140.00 (Benchmark, 18.34%) | Buy | |
| Average | 145.00 (22.57%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 120.64 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 22 May 2025 | 140.00 (18.34%) | Buy | 118.16 |
| Truist Securities | 28 Apr 2025 | 150.00 (26.80%) | Buy | 122.78 |
| 11 Apr 2025 | 140.00 (18.34%) | Buy | 116.50 | |
| Benchmark | 25 Apr 2025 | 140.00 (18.34%) | Buy | 123.41 |
| Raymond James | 25 Apr 2025 | 150.00 (26.80%) | Buy | 123.41 |
| Keybanc | 21 Apr 2025 | 145.00 (22.57%) | Buy | 115.44 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 26 Jun 2025 | Announcement | Integer Announces Conference Call to Discuss Second Quarter 2025 Results |
| 03 Jun 2025 | Announcement | Integer to Present at Truist Securities MedTech Conference on June 17 |
| 29 Apr 2025 | Announcement | Integer to Present at Bank of America Securities Health Care Conference on May 14 |
| 24 Apr 2025 | Announcement | Integer Announces CEO Succession Plan |
| 24 Apr 2025 | Announcement | Integer Holdings Corporation Reports First Quarter 2025 Results |
| 11 Apr 2025 | Announcement | Integer Holdings Corporation Issues Statement on Tariffs |
| 02 Apr 2025 | Announcement | Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |